Cited by 518Cancer Cells and MetastasisMesenchymal stem cell researchHematopoietic Stem Cell Transplantation

Cancer stem cell niche: the place to be

Open access
Borovski, Tijana, De Sousa E Melo, Felipe, Vermeulen, Louis, Medema, Jan Paul·2011·Cancer Research

Abstract

Tumors are being increasingly perceived as abnormal organs that, in many respects, recapitulate the outgrowth and differentiation patterns of normal tissues. In line with this idea is the observation that only a small fraction of tumor cells is capable of initiating a new tumor. Because of the features that these cells share with somatic stem cells, they have been termed cancer stem cells (CSC). Normal stem cells reside in a “stem cell niche” that maintains them in a stem-like state. Recent data suggest that CSCs also rely on a similar niche, dubbed the “CSC niche,” which controls their self-renewal and differentiation. Moreover, CSCs can be generated by the microenvironment through induction of CSC features in more differentiated tumor cells. In addition to a role in CSC maintenance, the microenvironment is hypothesized to be involved in metastasis by induction of the epithelial-mesenchymal transition, leading to dissemination and invasion of tumor cells. The localization of secondary tumors also seems to be orchestrated by the microenvironment, which is suggested to form a premetastatic niche. Thus, the microenvironment seems to be of crucial importance for primary tumor growth as well as metastasis formation. Combined with its role in the protection of CSCs against genotoxic insults, these data strongly put forward the niche as an important target for novel therapies. Cancer Res; 71(3); 634–9. ©2011 AACR.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/0008-5472.can-10-3220

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • This could lead to promotion of a pro-resting cancer stem cell niche for the most therapy-resistant stem-like cells, or to recruitment and promotion of tumorigenesis for more active progenitor cells.

    “This may result into promotion of a pro-resting CSC niche [152, 153] for the most therapy-resistant stem-like cells, or recruitment and promotion of tumorigenesis for more active progenitor cells.”

    From Mesenchymal stem cell secretome and regenerative therapy after cancer (2013) · cites this paper as [152]

    The Introduction says the CSC niche shelters cancer stem cells from genotoxic insults and contributes to their therapy resistance. It does not describe the niche as promoting a resting or quiescent state. The citation is attached to the niche claim, so the subsequent alternative about active progenitor cells is not the basis of this verdict. (LLM, conf=0.84)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Borovski, T., De Sousa E Melo, F., Vermeulen, L., & Medema, J. P.
Affiliations
  • Amsterdam UMC Location University of Amsterdam (NL)
  • Authors' Affiliations: Laboratory for Experimental Oncology and Radiobiology (LEXOR), Center for Experimental Molecular Medicine (CEMM), Academic Medical Center (AMC), University of Amsterdam, Amsterdam, the Netherlands
Corresponding author
Medema, Jan Paul
Venue
Cancer Research
Published
2011-02-01
Volume
71
Issue
3
Pages
634-639
ISSN
  • 0008-5472 (ISSN-L)
  • 1538-7445
OpenAlex
W2146267383
Cited by
518
References
49
Citations by year
2026: 4 · 2025: 8 · 2024: 24 · 2023: 24 · 2022: 18 · 2021: 30 · 2020: 39 · 2019: 39 · 2018: 30 · 2017: 51 · 2016: 45 · 2015: 46 · 2014: 51 · 2013: 49 · 2012: 41
FWCI
4.70
Type
journal article
Language
en
Open access
Locations
  • Cancer Research (publishedVersion)
  • PubMed (publishedVersion)
  • Pure Amsterdam UMC (publishedVersion)
  • UvA-DARE (University of Amsterdam) (submittedVersion, other-oa)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
  • Pure Amsterdam UMC (submittedVersion)
  • Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
Topics
  • Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
  • Health Sciences › Medicine › Genetics › Mesenchymal stem cell research
  • Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
Keywords
cancer stem cells, tumor microenvironment, stem cell niche, self-renewal, tumor differentiation, metastasis, epithelial-mesenchymal transition, pre-metastatic niche, tumor initiation
MeSH terms
Animals, Humans, Neoplasms, Neoplastic Stem Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review